TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS
· Delayed Price · Currency is USD
0.3400
+0.0300 (9.68%)
May 16, 2025, 4:00 PM EDT
TC Biopharm (Holdings) Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -12.15 | -5.91 | -1.31 | -13.58 | -5.46 | Upgrade
|
| Depreciation & Amortization | 0.43 | 0.63 | 0.77 | 1.01 | 1.08 | Upgrade
|
| Other Amortization | - | 0 | - | 0.02 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.01 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.13 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 1.01 | 0.44 | 1.12 | - | 0.8 | Upgrade
|
| Other Operating Activities | 0.04 | -7.26 | -9.18 | 7.2 | 0.07 | Upgrade
|
| Change in Accounts Receivable | - | - | - | -0.59 | 1.73 | Upgrade
|
| Change in Accounts Payable | -0.61 | 2.27 | -1.94 | 2.34 | 0.33 | Upgrade
|
| Change in Unearned Revenue | - | - | -3.84 | -1.98 | -1.98 | Upgrade
|
| Change in Income Taxes | 0.39 | 0.68 | -0.31 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -1.81 | -1.41 | -0.6 | - | - | Upgrade
|
| Operating Cash Flow | -12.57 | -10.54 | -15.29 | -5.58 | -3.43 | Upgrade
|
| Capital Expenditures | -0.06 | -0.11 | -0.24 | -0.02 | -0.03 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.06 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.03 | -0.1 | -0.12 | -0.12 | -0.17 | Upgrade
|
| Investing Cash Flow | -0.09 | -0.21 | -0.31 | -0.14 | -0.2 | Upgrade
|
| Short-Term Debt Issued | - | - | 0.02 | 6.38 | - | Upgrade
|
| Total Debt Issued | - | - | 0.02 | 6.38 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -2.63 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.12 | -0.42 | Upgrade
|
| Total Debt Repaid | - | - | -2.63 | -0.12 | -0.42 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -2.61 | 6.26 | -0.42 | Upgrade
|
| Issuance of Common Stock | 11.9 | 4.19 | 3.37 | 0.29 | 3.9 | Upgrade
|
| Other Financing Activities | -0.44 | 4.33 | 17.9 | -0.02 | -0.05 | Upgrade
|
| Financing Cash Flow | 11.46 | 8.52 | 18.65 | 6.53 | 3.43 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.05 | -0.11 | 0.19 | 0.02 | -0 | Upgrade
|
| Net Cash Flow | -1.25 | -2.35 | 3.24 | 0.82 | -0.21 | Upgrade
|
| Free Cash Flow | -12.63 | -10.66 | -15.53 | -5.6 | -3.47 | Upgrade
|
| Free Cash Flow Margin | - | - | -404.03% | -283.07% | -175.21% | Upgrade
|
| Free Cash Flow Per Share | -133.85 | - | - | - | - | Upgrade
|
| Cash Interest Paid | - | - | - | 0.25 | 0.29 | Upgrade
|
| Cash Income Tax Paid | - | - | - | -1.18 | -1.24 | Upgrade
|
| Levered Free Cash Flow | -8.6 | -12.42 | -8.5 | -4.3 | -0.74 | Upgrade
|
| Unlevered Free Cash Flow | -8.6 | -12.37 | -4.28 | -2.15 | -0.56 | Upgrade
|
| Change in Net Working Capital | 1.95 | 4.34 | -1.75 | -1.52 | -2.07 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.